The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Share News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.10
Bid: 8.10
Ask: 8.30
Change: 0.00 (0.00%)
Spread: 0.20 (2.469%)
Open: 8.10
High: 0.00
Low: 0.00
Prev. Close: 8.10
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS: Genus chair buys as shares sink on profit warning

Wed, 24th Nov 2021 16:05

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Wednesday and not separately reported by Alliance News:

----------

Kin & Carta PLC - London-based business consultancy - Marie James Capital LLC, a holding company managed by Chief Executive Officer John Schwan on behalf of his children's estate, sells 5 million shares, a 2.9% stake, via an accelerated bookbuild run by Numis Securities Ltd and Peel Hunt LLP, Numis confirms on Wednesday. The sale at 301 pence is worth GBP15.1 million. Schwan's investment vehicle continues to hold a 1.5% stake in Kin & Carta, and this is subject to a 12-month lock-up. Additionally, he directly holds 8.0 million shares, a 4.6% stake, according to Morningstar.

----------

LondonMetric Property PLC - invests in distribution and long-income properties across UK - Non-Executive Chair Patrick Vaughan sells 400,000 shares at 271p, worth GBP1.1 million, on Tuesday. Retains 10.3 million shares.

----------

Genus PLC - Basingstoke, Hampshire-based biotechnology products for cattle and pig farmers - Chair Iain Ferguson and wife Catherine buy 5,000 shares at average 4,476.5 pence and 4,495.6p, worth GBP224,016, on Wednesday. Shares in Genus sink more than 10% on Wednesday after the firm reports difficulties in the Chinese pig market. Ferguson, the former chief executive of sweeteners and food ingredients firm Tate & Lyle PLC, took the Genus chair in July 2020.

----------

Aston Martin Lagonda Global Holdings PLC - Warwick-based luxury carmaker - Non-Executive Director Anne Stevens buys 7,000 shares at GBP15.81, worth GBP110,670, on Tuesday.

----------

Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic biomarkers - Non-Executive Director Stephen Diggle buys 100,000 shares via Vulpes Life Sciences Fund at 41.2 pence, worth GBP41,200, on Tuesday. Diggle had bought 198,004 shares on Thursday and Friday last week and 2.5 million shares on Tuesday last week. Diggle now is interested in 15.0 million shares, a 15% stake.

----------

EnQuest PLC - oil and gas production in UK North Sea and Malaysia - Chief Executive Amjad Bseisu buys 434,145 shares via investment vehicle Double A Ltd at GBP0.19, worth GBP82,488, on Tuesday.

----------

Carclo PLC - West Yorkshire-based plastic parts manufacturer - Executive Chair Nick Sanders buys 127,219 shares at 38.95p, worth GBP49,552, on Tuesday.

----------

Dunedin Enterprise Investment Trust PLC - investor in UK mid-market management buyouts - Director Angela Lane sells 11,445 shares at GBP5.24, worth GBP59,953, on Thursday last week, as part of trust's tender offer.

----------

Record PLC - Windsor, Berkshire-based currency and derivatives manager - Non-Executive Director Krystyna Nowak buys 29,500 shares at GBP0.83, worth GBP24,574, on Wednesday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
16 Mar 2020 16:14

EXECUTIVE CHANGE SUMMARY: Globalworth Founder To Focus On Exec Role

EXECUTIVE CHANGE SUMMARY: Globalworth Founder To Focus On Exec Role

Read more
2 Mar 2020 19:43

CORRECT: Oxford BioDynamics Director Diggle Buys Shares

CORRECT: Oxford BioDynamics Director Diggle Buys Shares

Read more
26 Feb 2020 15:20

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

Read more
15 Jan 2020 15:17

Oxford BioDynamics Demonstrates Use Of EpiSwitch In Lymphoma Detection

Oxford BioDynamics Demonstrates Use Of EpiSwitch In Lymphoma Detection

Read more
23 Dec 2019 06:52

Oxford BioDynamics In Collaboration To Evaluate EpiSwitch Biomarkers

Oxford BioDynamics In Collaboration To Evaluate EpiSwitch Biomarkers

Read more
20 Dec 2019 10:43

UK WINNERS & LOSERS SUMMARY: Renewi Jumps 23% As Dutch Eco Ban Lifted

UK WINNERS & LOSERS SUMMARY: Renewi Jumps 23% As Dutch Eco Ban Lifted

Read more
11 Dec 2019 17:52

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

Read more
11 Dec 2019 16:11

Director dealings: Oxford Biodynamics interim chairman ups stake

(Sharecast News) - Oxford Biodynamics revealed on Wednesday that interim chairman Stephen Diggle had purchased 18,309 ordinary shares in the AIM-listed biotechnology firm.

Read more
10 Dec 2019 13:09

Oxford BioDynamics Annual Loss Widens On Increased Costs

Oxford BioDynamics Annual Loss Widens On Increased Costs

Read more
25 Oct 2019 11:58

Study Using Oxford BioDynamics' EpiSwitch Enrols First Patient

Study Using Oxford BioDynamics' EpiSwitch Enrols First Patient

Read more
28 Aug 2019 17:36

DIRECTOR DEALINGS: Oxford BioDynamics Director Diggle Buys Shares

(Alliance News) - Oxford BioDynamics PLC said that a company controlled by Non-Executive Director Stephen Diggle bought GBP36,000 worth of shares on Wednesday.Vulpes Life Sciences Fund, by

Read more
15 Aug 2019 15:36

DIRECTOR DEALINGS: Oxford BioDynamics Non-Executive Diggle Buys Shares

(Alliance News) - Oxford BioDynamics PLC on Thursday said Non-Executive Director Stephen Diggle acquired shares in the biotechnology company following a transaction on Wednesday.Diggle at a

Read more
6 Jun 2019 15:54

DIRECTOR DEALINGS: Non-Exec Linked Fund Buys Oxford BioDynamics Shares

LONDON (Alliance News) - Oxford BioDynamics PLC said Thursday that Vulpes Life Sciences Fund, controlled by Non-Executive Director Steven Diggle, purchased around GBP12,700 in shares in a on fund

Read more
31 May 2019 13:01

Long-Serving Oxford Biodynamics Non-Executive Kibble Stands Down

LONDON (Alliance News) - Biotechnology firm Oxford Biodynamics PLC said Friday Non-Executive Director Alison Kibble has stepped down from the firm after 11 years on the board.Kibble - first

Read more
28 May 2019 11:50

Oxford BioDynamics Half Year Loss Widens On Increased Costs

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday said its loss widened in the first half of its financial year due to higher staff and administrative costs.Shares in Oxford were a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.